Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iridoid glycosides are a class of plant-derived monoterpenoid compounds characterized by a bicyclic cyclopentapyran core structure with one or more sugar moieties attached via a glycosidic bond. They possess diverse pharmacological activities, including anti-inflammatory, antimicrobial, and antioxidant effects, and serve ecological roles in plant defense.
Cell cycle arrest or apoptosis induction via modulation of PI3K/Akt and ERK1/2-cyclin D1 pathways (some iridoid glycosides)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iridoid Glycoside.